CENTAURUS FINANCIAL, INC. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
CENTAURUS FINANCIAL, INC. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$834,000
-14.0%
25,065
+0.3%
0.07%
-14.6%
Q2 2021$970,000
-22.6%
25,000
-3.8%
0.08%
-33.9%
Q1 2021$1,253,000
-7.4%
26,0000.0%0.12%
-12.7%
Q4 2020$1,353,000
+94.4%
26,0000.0%0.14%
+47.9%
Q3 2020$696,000
+78.5%
26,000
+30.0%
0.10%
+65.5%
Q2 2020$390,000
+163.5%
20,000
+33.3%
0.06%
+93.3%
Q1 2020$148,000
+33.3%
15,000
+50.0%
0.03%
+87.5%
Q4 2019$111,000
+98.2%
10,0000.0%0.02%
+77.8%
Q3 2019$56,000
-35.6%
10,0000.0%0.01%
-35.7%
Q2 2019$87,000
-99.1%
10,000
+12400.0%
0.01%
-76.3%
Q1 2019$10,000,000800.06%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders